Structural identity

Sequence length
4 residues
Molecular weight
639.79 Da
Molecular formula
C32H49N9O5

Sequence

[d-Arg]-[2'6'-Dmt]-Lys-Phe-NH2

Also known as: elamipretide · mtp-131 · bendavia

Structural notes. Contains a 2',6'-dimethyltyrosine at position 2. Szeto HH, 2014, Br J Pharmacol 171(8):2029.

Catalog handling boundary

This reference records structural identity only. Laboratory handling and preparation must follow the product label, any verified order-specific documentation, and the qualified laboratory's validated in-vitro protocol.

No universal diluent, concentration, shelf-life, or storage condition is asserted on this public page. Nothing here is a human or veterinary dosing, administration, or preparation instruction.

What the primary literature describes

The references below describe in-vitro, preclinical, or structural observations cited in published peer-reviewed work. What the literature reports is summarized in chemistry terms. The references are cited because they describe the molecule — its sequence, its structure, its receptor interactions — not because they support any outcome claim.

  • Contains a 2',6'-dimethyltyrosine at position 2. Szeto HH, 2014, Br J Pharmacol 171(8):2029.

What is not established here

This page does not state, imply, or summarize any therapeutic outcome. The molecule is presented as a chemistry object — sequence, mass, structural family, and the structural-characterization literature that describes it. Dose-response relationships in any specific in-vitro model system, claims of efficacy in any human or animal context, and outcome statements of any kind are deliberately outside the scope of this page.

What a qualified investigator chooses to investigate, and how, is the investigator's responsibility under their institution's research-use framework. Peptides.vc supplies the reagent and the chemistry-only reference data; nothing more is implied.

For research use only. Not for human or animal consumption.